{
    "medicine_id": "a195223ab216b7af39cd38b019043ca2e50ebe97",
    "platform_id": "DB05875",
    "metadata": {
        "name": "Natpar 100 MCG Injection powder for solution",
        "composition": "100 MCG Sar9 Met O2 11 Substance P",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for use treatment in acute respiratory distress syndrome ARDS and viral infection",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "NA",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00082",
                        "description": "Pegvisomant may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB00358",
                        "description": "Mefloquine may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB00382",
                        "description": "Tacrine may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB00391",
                        "description": "Sulpiride may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB00392",
                        "description": "Profenamine may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "Chlorpromazine may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB00483",
                        "description": "Gallamine triethiodide may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB00508",
                        "description": "Triflupromazine may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB00515",
                        "description": "Cisplatin may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB00527",
                        "description": "Cinchocaine may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB00545",
                        "description": "Pyridostigmine may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB00585",
                        "description": "Nizatidine may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB00674",
                        "description": "Galantamine may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB00677",
                        "description": "Isoflurophate may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB00711",
                        "description": "Diethylcarbamazine may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB00721",
                        "description": "Procaine may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB00805",
                        "description": "Minaprine may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB00843",
                        "description": "Donepezil may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB00871",
                        "description": "Terbutaline may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB00888",
                        "description": "Mechlorethamine may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB00941",
                        "description": "Hexafluronium may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB00944",
                        "description": "Demecarium may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB00981",
                        "description": "Physostigmine may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB00989",
                        "description": "Rivastigmine may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB01010",
                        "description": "Edrophonium may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB01035",
                        "description": "Procainamide may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB01043",
                        "description": "Memantine may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB01122",
                        "description": "Ambenonium may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB01199",
                        "description": "Tubocurarine may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB01221",
                        "description": "Ketamine may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB01233",
                        "description": "Metoclopramide may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB01245",
                        "description": "Decamethonium may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB01337",
                        "description": "Pancuronium may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB01338",
                        "description": "Pipecuronium may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB01381",
                        "description": "Ginkgo biloba may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB01400",
                        "description": "Neostigmine may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB01408",
                        "description": "Bambuterol may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB02365",
                        "description": "1 10 Phenanthroline may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB04572",
                        "description": "Thiotepa may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB04864",
                        "description": "Huperzine A may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB04892",
                        "description": "Phenserine may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB05386",
                        "description": "Regramostim may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB06692",
                        "description": "Aprotinin may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB06756",
                        "description": "Glycine betaine may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB06774",
                        "description": "Capsaicin may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB11390",
                        "description": "Coumaphos may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB11397",
                        "description": "Dichlorvos may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB11412",
                        "description": "Fenthion may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB11473",
                        "description": "Metrifonate may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB12482",
                        "description": "Acotiamide may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB13058",
                        "description": "Methanesulfonyl Fluoride may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB13495",
                        "description": "Paraoxon may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB13503",
                        "description": "Tyrothricin may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB13668",
                        "description": "Ipidacrine may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB13694",
                        "description": "Distigmine may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB14031",
                        "description": "Tretamine may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB15317",
                        "description": "Posiphen may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB02845",
                        "description": "Methylphosphinic Acid may increase the neuromuscular blocking activities of Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB00202",
                        "description": "The serum concentration of Sar9 Met O2 11 Substance P can be increased when it is combined with Succinylcholine"
                    },
                    {
                        "drugbank-id": "DB00762",
                        "description": "The serum concentration of Sar9 Met O2 11 Substance P can be increased when it is combined with Irinotecan"
                    },
                    {
                        "drugbank-id": "DB00907",
                        "description": "The serum concentration of Sar9 Met O2 11 Substance P can be increased when it is combined with Cocaine"
                    },
                    {
                        "drugbank-id": "DB01116",
                        "description": "The serum concentration of Sar9 Met O2 11 Substance P can be increased when it is combined with Trimethaphan"
                    },
                    {
                        "drugbank-id": "DB01135",
                        "description": "The serum concentration of Sar9 Met O2 11 Substance P can be increased when it is combined with Doxacurium"
                    },
                    {
                        "drugbank-id": "DB01161",
                        "description": "The serum concentration of Sar9 Met O2 11 Substance P can be increased when it is combined with Chloroprocaine"
                    },
                    {
                        "drugbank-id": "DB01364",
                        "description": "The serum concentration of Sar9 Met O2 11 Substance P can be increased when it is combined with Ephedrine"
                    },
                    {
                        "drugbank-id": "DB04920",
                        "description": "The serum concentration of Sar9 Met O2 11 Substance P can be increased when it is combined with Clevidipine"
                    },
                    {
                        "drugbank-id": "DB08893",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB08897",
                        "description": "The serum concentration of Aclidinium can be increased when it is combined with Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB09205",
                        "description": "The serum concentration of Moxisylyte can be increased when it is combined with Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB09288",
                        "description": "The serum concentration of Propacetamol can be increased when it is combined with Sar9 Met O2 11 Substance P"
                    },
                    {
                        "drugbank-id": "DB04250",
                        "description": "The serum concentration of Sar9 Met O2 11 Substance P can be increased when it is combined with Butyrylthiocholine"
                    },
                    {
                        "drugbank-id": "DB00892",
                        "description": "The serum concentration of Sar9 Met O2 11 Substance P can be increased when it is combined with Oxybuprocaine"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}